文献速递角膜与眼表疾病

DSAEK术后3年内皮细胞丢失的相关因素:供体、受体与手术因素分析

Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

该研究为角膜保存时间研究(CPTS)的二次分析,纳入749例(913眼)DSAEK术后有功能移植片且内皮图像合格者,评估供体、受体及手术因素与3年内皮细胞密度(ECD)的关联。多变量模型显示供体糖尿病、较低筛查ECD、受体诊断为无晶状体/人工晶状体性角膜水肿(PACE)及术中并发症与3年ECD较低相关,其余因素无显著关联。

要点

  • 供体糖尿病与3年ECD较低相关(估计效应-103 cells/mm2,99%CI -196至-9)。
  • 受体诊断为PACE与3年ECD较低相关(估计效应-257 cells/mm2,99%CI -483至-31)。
  • 术中并发症与3年ECD较低相关(估计效应-324 cells/mm2,99%CI -516至-133)。

核心结论

  • 供体糖尿病、较低筛查ECD、受体PACE诊断及术中并发症与DSAEK术后3年ECD较低相关,可能关联长期移植片存活。
  • 不能推断因果关系,供体糖尿病与受体PACE和3年ECD较低的关联值得进一步研究。

研究设计与样本

  • 多中心、双盲、随机临床试验(CPTS)的队列二次分析,纳入美国40个临床中心70名术者及23家眼库供体角膜。
  • 纳入Fuchs营养不良或人工晶状体/无晶状体性角膜水肿行DSAEK者,随机分配供体角膜保存时间0-7天或8-14天。
  • 共1090例参与者(1330眼)中,749例(913眼)术前及术后3年内皮图像合格且有功能移植片者纳入本分析。

主要发现

  • 3年ECD较低相关因素(估计效应,99%CI):供体糖尿病-103(-196至-9)cells/mm2,筛查ECD每低500 cells/mm2为-234(-331至-137)。
  • 受体PACE诊断-257(-483至-31)cells/mm2,术中并发症-324(-516至-133)cells/mm2。
  • 术前至术后3年内皮细胞丢失率:供体糖尿病者47%(99%CI 42%-52%) vs 无糖尿病者43%(99%CI 39%-48%)。
  • PACE诊断者53%(99%CI 44%-62%) vs Fuchs营养不良者44%(99%CI 39%-49%)。
  • 术中并发症者55%(99%CI 48%-63%) vs 无并发症者44%(99%CI 39%-48%)。

关键数值与推荐

  • 3年ECD较低相关因素(估计效应,99%CI):供体糖尿病-103(-196至-9)cells/mm2,筛查ECD每低500 cells/mm2为-234(-331至-137)。
  • 受体PACE诊断-257(-483至-31)cells/mm2,术中并发症-324(-516至-133)cells/mm2。
  • 术前至术后3年内皮细胞丢失率:供体糖尿病者47%(99%CI 42%-52%) vs 无糖尿病者43%(99%CI 39%-48%)。
  • PACE诊断者53%(99%CI 44%-62%) vs Fuchs营养不良者44%(99%CI 39%-49%)。
  • 术中并发症者55%(99%CI 48%-63%) vs 无并发症者44%(99%CI 39%-48%)。

临床怎么用

  • 对供体糖尿病、低筛查ECD、受体PACE诊断或术中并发症的DSAEK病例,应预期3年内皮细胞密度更低并加强随访。
  • 术前可结合供体糖尿病史与筛查ECD评估移植片长期存活风险,术中尽量避免并发症。

局限性

  • 本研究为二次分析,不能推断因果关系。
  • 仅纳入术前及术后3年内皮图像合格且有功能移植片的患眼,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Determining factors associated with endothelial cell loss after Descemet stripping automated endothelial keratoplasty (DSAEK) could improve long-term graft survival. OBJECTIVE: To evaluate the associations of donor, recipient, and operative factors with endothelial cell density (ECD) 3 years after DSAEK in the Cornea Preservation Time Study. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a secondary analysis of data collected in a multicenter, double-masked, randomized clinical trial. Forty US clinical sites with 70 surgeons participated, with donor corneas provided by 23 US eye banks. Individuals undergoing DSAEK for Fuchs dystrophy or pseudophakic/aphakic corneal edema were included. INTERVENTIONS: The DSAEK procedure, with random assignment of a donor cornea with a preservation time of 0 to 7 days or 8 to 14 days. MAIN OUTCOMES AND MEASURES: Endothelial cell density at 3 years as determined by a reading center from eye bank and clinical specular or confocal central endothelial images. RESULTS: The study included 1090 participants (median age, 70 years) with 1330 affected eyes (240 bilateral cases [22.0%]), who underwent DSAEK for Fuchs dystrophy (1255 eyes [94.4%]) or pseudophakic/aphakic corneal edema (PACE) (75 eyes [5.6%]). Of these, 801 eyes (60.2%) belonged to women and 1207 (90.8%) to white individuals. A total of 749 participants (913 eyes; 164 [21.9%] bilateral cases) had functioning grafts with acceptable endothelial images preoperatively and at 3 years postoperatively and were included in this analysis. Factors associated with a lower ECD at 3 years (estimated effect with 99% CI) in the final multivariable model included donors with diabetes (-103 [-196 to -9] cells/mm2), lower screening ECD (-234 [-331 to -137] per 500 cells/mm2), recipient diagnosis of PACE (-257 [-483 to -31] in cells/mm2), and operative complications (-324 [-516 to -133] in cells/mm2). Endothelial cell loss (ECL) from a preoperative measurement to a 3-year postoperative measurement was 47% (99% CI, 42%-52%) for participants receiving tissue from donors with diabetes vs 43% (99% CI, 39%-48%) without diabetes; it was 53% (99% CI, 44%-62%) for participants diagnosed with PACE vs 44% (99% CI, 39%-49%) for those diagnosed with Fuchs dystrophy, and 55% (99% CI, 48%-63%) in participants who experienced operative complications vs 44% (99% CI, 39%-48%) in those who did not. No other donor, recipient, or operative factors were significantly associated with 3-year ECD. CONCLUSIONS AND RELEVANCE: Donor diabetes, lower screening ECD, a PACE diagnosis in the recipient, and operative complications were associated with lower ECD at 3 years after DSAEK surgery and may be associated with long-term graft success. While causation cannot be inferred, further studies on the association of donor diabetes and PACE in recipients with lower 3-year ECD warrant further study.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lass JH, Benetz BA, Patel SV, et al. Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study. JAMA Ophthalmol. 2019. PMID: 30422157. doi:10.1001/jamaophthalmol.2018.5669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。